Analysis of von Willebrand Disease in the South Moravian
Population (Czech Republic): Results from the BRNO-VWD Study

J 2019

Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study

VANGENECHTEN, Inge, Petr SMEJKAL, Ondřej ZAPLETAL, Jan Jacques MICHIELS, Zwi BERNEMAN et. al.

Základní údaje

Originální název

Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study

Autoři

VANGENECHTEN, Inge (372 Irsko, garant), Petr SMEJKAL (203 Česká republika, domácí), Ondřej ZAPLETAL (203 Česká republika), Jan Jacques MICHIELS (528 Nizozemské království), Zwi BERNEMAN (56 Belgie), Jiřina ZAVŘELOVÁ (203 Česká republika, domácí), Jan BLATNÝ (203 Česká republika), Miroslav PENKA (203 Česká republika, domácí) a Alain GADISSEUR (56 Belgie)

Vydání

THROMBOSIS AND HAEMOSTASIS, STUTTGART, GEORG THIEME VERLAG KG, 2019, 0340-6245

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30205 Hematology

Stát vydavatele

Německo

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.385

Kód RIV

RIV/00216224:14110/19:00109814

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1055/s-0039-1678528

UT WoS

000463041700011

Klíčová slova anglicky

classification; mutations; von Willebrand disease; von Willebrand factor; von Willebrand factor assays

Štítky

110616, 14110616, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 3. 6. 2019 08:29, Soňa Böhmová

Anotace

V originále

Background von Willebrand disease (VWD) is an inherited bleeding disorder caused by a quantitative (type 1 and 3) or qualitative (type 2) defect of von Willebrand factor (VWF). The heterogeneity of laboratory phenotyping makes diagnosing difficult. Objective A cross-sectional, family-based VWD study in a collaboration between University Hospital Brno (Czech Republic) and Antwerp University Hospital (Belgium) to improve the understanding of laboratory phenotype/genotype correlation. Patients and Methods A total of 205 patients with suspected VWD were identified from historical records. Complete laboratory analysis was established using all available VWD assays including VWF multimers and genetic analysis. Results Based on the current International Society of Thrombosis and Haemostasis (ISTH) - Scientific and Standardization Committee VWD classification and type 2A sub-division into 2A/IIA, IID, IIC and HE, the majority was characterized as a type 1 VWD, followed by type 2. Proposed laboratory phenotypes were confirmed by their multimeric pattern within 98% of this cohort. All type 2, 3 and 75% of type 1 VWD patients were confirmed by underlying causative mutations. Forty-six different causal mutations (117 not previously described in the literature) could be identified. Fifty per cent of all cases was represented by eight individual mutations, mainly p.Pro812ArgfsX31. Thirteen patients had a large heterozygous gene alteration. Conclusion Although an extensive panel of tests was used, VWD classification and (sub)typing remains difficult and fluid. This study provides a cross-sectional overview of the VWD population in the Czech Republic and provides important data to the ISTH/ European Association for Haemophilia and Allied Disorders VWD mutation database in linking causal mutations with unique VWD (sub)types. It also identifies new, as not previously described in the literature, causal mutations.

Citovat

VANGENECHTEN, Inge, Petr SMEJKAL, Ondřej ZAPLETAL, Jan Jacques MICHIELS, Zwi BERNEMAN, Jiřina ZAVŘELOVÁ, Jan BLATNÝ, Miroslav PENKA a Alain GADISSEUR. Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study. THROMBOSIS AND HAEMOSTASIS. STUTTGART: GEORG THIEME VERLAG KG, 2019, roč. 119, č. 4, s. 594-605. ISSN 0340-6245. Dostupné z: https://dx.doi.org/10.1055/s-0039-1678528.

@article{1536296,
   author = {Vangenechten, Inge and Smejkal, Petr and Zapletal, Ondřej and Michiels, Jan Jacques and Berneman, Zwi and Zavřelová, Jiřina and Blatný, Jan and Penka, Miroslav and Gadisseur, Alain},
   article_location = {STUTTGART},
   article_number = {4},
   doi = {http://dx.doi.org/10.1055/s-0039-1678528},
   keywords = {classification; mutations; von Willebrand disease; von Willebrand factor; von Willebrand factor assays},
   language = {eng},
   issn = {0340-6245},
   journal = {THROMBOSIS AND HAEMOSTASIS},
   title = {Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study},
   url = {http://dx.doi.org/10.1055/s-0039-1678528},
   volume = {119},
   year = {2019}
}

TY  - JOUR
ID  - 1536296
AU  - Vangenechten, Inge - Smejkal, Petr - Zapletal, Ondřej - Michiels, Jan Jacques - Berneman, Zwi - Zavřelová, Jiřina - Blatný, Jan - Penka, Miroslav - Gadisseur, Alain
PY  - 2019
TI  - Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study
JF  - THROMBOSIS AND HAEMOSTASIS
VL  - 119
IS  - 4
SP  - 594-605
EP  - 594-605
PB  - GEORG THIEME VERLAG KG
SN  - 03406245
KW  - classification
KW  - mutations
KW  - von Willebrand disease
KW  - von Willebrand factor
KW  - von Willebrand factor assays
UR  - http://dx.doi.org/10.1055/s-0039-1678528
L2  - http://dx.doi.org/10.1055/s-0039-1678528
N2  - Background von Willebrand disease (VWD) is an inherited bleeding disorder caused by a quantitative (type 1 and 3) or qualitative (type 2) defect of von Willebrand factor (VWF). The heterogeneity of laboratory phenotyping makes diagnosing difficult. Objective A cross-sectional, family-based VWD study in a collaboration between University Hospital Brno (Czech Republic) and Antwerp University Hospital (Belgium) to improve the understanding of laboratory phenotype/genotype correlation. Patients and Methods A total of 205 patients with suspected VWD were identified from historical records. Complete laboratory analysis was established using all available VWD assays including VWF multimers and genetic analysis. Results Based on the current International Society of Thrombosis and Haemostasis (ISTH) - Scientific and Standardization Committee VWD classification and type 2A sub-division into 2A/IIA, IID, IIC and HE, the majority was characterized as a type 1 VWD, followed by type 2. Proposed laboratory phenotypes were confirmed by their multimeric pattern within 98% of this cohort. All type 2, 3 and 75% of type 1 VWD patients were confirmed by underlying causative mutations. Forty-six different causal mutations (117 not previously described in the literature) could be identified. Fifty per cent of all cases was represented by eight individual mutations, mainly p.Pro812ArgfsX31. Thirteen patients had a large heterozygous gene alteration. Conclusion Although an extensive panel of tests was used, VWD classification and (sub)typing remains difficult and fluid. This study provides a cross-sectional overview of the VWD population in the Czech Republic and provides important data to the ISTH/ European Association for Haemophilia and Allied Disorders VWD mutation database in linking causal mutations with unique VWD (sub)types. It also identifies new, as not previously described in the literature, causal mutations.
ER  -

VANGENECHTEN, Inge, Petr SMEJKAL, Ondřej ZAPLETAL, Jan Jacques MICHIELS, Zwi BERNEMAN, Jiřina ZAVŘELOVÁ, Jan BLATNÝ, Miroslav PENKA a Alain GADISSEUR. Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study. \textit{THROMBOSIS AND HAEMOSTASIS}. STUTTGART: GEORG THIEME VERLAG KG, 2019, roč.~119, č.~4, s.~594-605. ISSN~0340-6245. Dostupné z: https://dx.doi.org/10.1055/s-0039-1678528.

Podrobný výpis o publikaci